Go back to News
NEWS
GA_P advises Atrys Health on the capital increase for the acquisition of Bienzobas Salud
Gómez-Acebo & Pombo has advised Atrys Health in a structured transaction through the sale of a package of existing shares and a capital increase to finance the acquisition of Bienzobas Salud for 75 million euros, carried out through an accelerated bookbuild offering/ an accelerated private placement procedure exclusively addressed to qualified domestic and foreign investors,, executed by Barclays Bank Ireland PLC (as Sole Global Coordinator) and Andbank España, S.A.U., Banco de Sabadell, S.A., GVC Gaesco Valores, S.V., S.A. and Renta 4 Banco, S.A. (as Co-Bookrunners), which have been advised by Linklaters.
The GA_P team was integrated by Guillermo Guerra, partner of the Corporate department, Jacobo Palanca and Emiliano Moreno, lawyers of the Corporate department and Irene Medina de Alba, lawyer of the Banking and Capital Markets department.
The GA_P team was integrated by Guillermo Guerra, partner of the Corporate department, Jacobo Palanca and Emiliano Moreno, lawyers of the Corporate department and Irene Medina de Alba, lawyer of the Banking and Capital Markets department.
Lawyer mentioned
Guillermo Guerra – Partner
Jacobo Palanca – Senior Associate
Tipology
Deal
Press contact

Sandra Cuesta
Director of Business Development, Marketing and Communications

Sandra Cuesta
Director of Business Development, Marketing and Communications
More information about
Gómez-Acebo & Pombo
PUBLICATION
06 Mar, 2025
Calling of meeting of shareholders, abuse of rights, resistance test
Once again: despite compliance with the formal requirements of a calling of meeting of shareholders, company resolutions may be unenforceable if there is an abuse of rights in said call
PUBLICATION
04 Mar, 2025
Rules to determine directors' remuneration: a case where Article 217(4) of the Companies Act applies
The Supreme Court applies the rules set out in Article 217(4) of the Companies Act to reach a decision concerning the contest of a board resolution that determined the remuneration of a company director.
PUBLICATION
27 Feb, 2025
An end to rules on racial, gender and LGTBQ+ diversity on Nasdaq-listed company boards
In Alliance for Fair Board Recruitment; NCPPR v. SEC, the U.S. Court of Appeals vacates, by a one-vote margin, the Securities & Exchange Commission’s approval in 2021 of Nasdaq’s rules on board diversity for companies listed on its exchange.
PUBLICATION
11 Feb, 2025
The concept of transferable securities and the exclusion of municipalities as qualified investors for the purposes of prospectus publications: CJEU judgment of 9 January 2025
In this judgment, the CJEU considers that shares whose transfer is subject to approval by the board of directors can be considered transferable securities for the purposes of the European prospectus legislation and MiFID.
PUBLICATION
19 Nov, 2024
Mandatory recognition of multiple-vote shares for companies listed on a multilateral trading facility
Directive (EU) 2024/2810 of the European Parliament and of the Council of 23 October 2024 on multiple-vote share structures in companies that seek admission to trading of their shares on a multilateral trading facility will have to be transposed into Spanish law before 5 December 2026
PUBLICATION
04 Nov, 2024
Listing Act amendments to the Prospectus Regulation
The reform of the Prospectus Regulation to facilitate access to funding through securities markets, especially by SMEs, is pending publication in the OJEU.
PUBLICATION
10 Sep, 2024
Mandatory presence of female directors in listed companies and other public interest entities
PUBLICATION
31 Jul, 2024
New amendments to MiFID II to facilitate SMEs’ access to securities markets
The Listing Act amends MiFID II and repeals the Admissions Directive.
PUBLICATION
22 May, 2024
Reform of the market abuse regime by the Listing Act
The European Parliament has approved in first reading the amendments to the Market Abuse Regulation in order to reduce administrative burdens for issuers and clarify some controversial issues in practice.